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Purpose—To identify the genetic cause and describe the phenotype in four families with 
autosomal recessive retinitis pigmentosa (arRP) that can be associated with pseudocoloboma.
Design—Case series.
Subjects—Seven patients from four unrelated families with arRP of which three patients had 
bilateral early-onset macular pseudocoloboma.
Methods—We performed homozygosity mapping and whole-exome sequencing (WES) in five 
probands and two unaffected family members of four unrelated families. Subsequently, Sanger 
sequencing and segregation analysis were done in additional family members. We reviewed the 
medical history of individuals carrying IDH3A variants and performed additional ophthalmic 
examinations, including full-field electroretinography (ffERG), fundus photography, fundus 
autofluorescence imaging and optical coherence tomography.
Main Outcome Measures—IDH3A variants, age at diagnosis, visual acuity, fundus 
appearance, visual field, ffERG, fundus autofluorescence and OCT findings.
Results—We identified seven different variants in IDH3A in four unrelated families, i.e. five 
missense, one nonsense and one frameshift variant. All subjects developed symptoms early in life 
ranging from night blindness to decreased visual acuity and were diagnosed between the ages of 
one and 11 years. Four subjects with biallelic IDH3A variants displayed a typical arRP phenotype 
and three subjects were diagnosed with arRP and pseudocoloboma of the macula.
Conclusions—IDH3A variants were identified as a novel cause of typical arRP, in some 
individuals associated with macular pseudocoloboma. We observed both phenotypes in two 
siblings carrying the same compound heterozygous variants, which could be explained by variable 
disease expression and warrants caution when making assertions about genotype-phenotype 
correlations.
Introduction
Inherited retinal diseases (IRDs) are a major cause of incurable blindness in children and 
young adults and are characterized by progressive degeneration of photoreceptor and/or 
retinal pigment epithelium (RPE) cells. Retinitis pigmentosa (RP) is the most common IRD, 
with a worldwide prevalence of approximately 1 per 4,000 individuals1–4. In typical RP, 
patients suffer from night blindness, visual field constriction, and eventually decreased 
visual acuity5. Characteristic fundus features of RP are bone spicule-like pigmentations, 
narrowed blood vessels, a waxy, pale appearance of the optic disk, and a relatively preserved 
macular region.
Leber congenital amaurosis (LCA) is considered the most severe and earliest occurring form 
of IRD, characterized by severe visual loss, roving eye movements or nystagmus and non-
recordable or severely reduced cone and rod electroretinography (ERG) amplitudes within 
the first year of life6. In practice, the demarcation between LCA and early-onset RP (also 
called juvenile RP or early onset retinal dystrophy (EORD)) is not always clear and 
nowadays both disorders are considered as part of the same spectrum due to clinical and 
molecular overlap.
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RP can be inherited in all Mendelian inheritance patterns, and non-Mendelian inheritance 
patterns such as digenic, mitochondrial or the occurrence of de novo mutations. Eighty-two 
genes have been associated with this disorder (Retnet; https://sph.uth.edu/retnet/). LCA 
mainly transmits in an autosomal recessive manner and 22 genes have been identified up to 
now, of which 12 overlap with early forms of RP. Mutations in these IRD-associated genes 
reveal various underlying biochemical pathways such as phototransduction, visual cycle 
regulation, ion homeostasis, cell structure maintenance, ciliary processes, pre-mRNA 
processing, gene transcription and lipid metabolism. In approximately 60% of LCA and RP 
cases disease-causing variants can be identified by whole-exome sequencing (WES)7–11. 
The remaining cases are interesting candidates for the identification of novel disease-
associated genes. By sharing WES data and homozygosity mapping data within the 
European Retinal Disease Consortium (ERDC; 15 research groups in 11 countries), we have 
been able to identify several new genes underlying IRDs12–15. In this study, we report 
IDH3A as a novel gene mutated in seven cases with autosomal recessive RP, with early 
macular involvement and pseudocoloboma.
Methods
Subjects and Clinical Evaluation
The study protocol adhered to the tenets of the Declaration of Helsinki and received 
approval from the respective local ethics committees. Written informed consent was 
obtained from all participants or parents of children prior to their inclusion in this study. 
Patients were ascertained in the Rotterdam Eye Hospital (Rotterdam, The Netherlands), 
Hadassah-Hebrew University Medical Center (Jerusalem, Israel), Leiden University Medical 
Center (The Netherlands) or recruited from the IRD registry in the Division of Human 
Genetics, University of Cape Town (South Africa).
A full medical and family history was taken and retrospective data were retrieved from 
referring ophthalmologists. Patients underwent a clinical examination including visual acuity 
testing and retinal imaging. Retinal fundus imaging was obtained by color fundus 
photography (Topcon Great Britain Ltd, Berkshire, UK). Fundus autofluorescence (FAF) 
imaging of the posterior pole with fundus-camera-based autofluorescence photography 
(Topcon Great Britain Ltd, Berkshire, UK) or confocal scanning laser ophthalmoscopy 
(cSLO) (Spectralis; Heidelberg Engineering Ltd, Heidelberg, Germany) and Spectral domain 
optical coherence tomography (SD-OCT). Wide angle color and autofluorescence fundus 
photos were obtained in two patients using an OPTOS system (model 200Tx, OPTOS Plc, 
Dunfermline, Scotland, United Kingdom). Color vision was evaluated using the Ishihara 38-
plate and the Farnsworth D-15 panel. Visual field (VF) testing was performed using a 
Goldmann kinetic perimeter.
Full-field electroretinography (ffERG) was available from five patients, which incorporated 
the International Society for Clinical Electrophysiology of Vision (ISCEV) standards. For 
two Dutch patients from family A DTL-electrodes (Diagnosys, Cambridge, UK) (patient A-
II:1) and skin electrodes (patient A-II:2) were used in combination with a computerized 
system (Espion Ganzfeld, Diagnosys, Cambridge, UK). Light and dark-adapted responses 
were measured in accordance with ISCEV extended protocol. The dark-adapted rod and 
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mixed responses were acquired after 20 minutes of dark adaptation; responses to different 
intensities were recorded from 0.0001 to 22 cds/m2 in 12 incremental steps. Under light 
adapted conditions the 30-Hz flicker and single flash responses from 0.3 to 10 cds/m2 in 
four incremental steps were recorded under a background light of 30cd/m2. Additionally, we 
performed S-cone specific testing by using an amber stimulus on a blue background and a 
blue stimulus on an amber background after one minute of dark adaptation. All ERG 
responses were acquired at a sample rate of 2000Hz and multiple sweeps were averaged. For 
two Israeli patients from family B ffERG was performed using monopolar corneal electrodes 
(Henkes type; Medical Workshop B.V., Groningen, The Netherlands) and a computerized 
system (UTAS 3000; LKC, Gaithersburg, MD, USA). Cone responses to 30-Hz flashes of 
white light were acquired under a background light of 21 cd/m2. Dark-adapted responses, 
including a rod response to a dim blue flash and a mixed cone-rod response to a standard 
white flash, were acquired after 30 to 45 minutes of dark adaptation. Between two and four 
sets of responses were recorded in each condition to verify repeatability. All ERG responses 
were filtered at 0.3 to 500 Hz, and signal averaging was applied. Responses were evaluated 
using local reference values.
Genetic analysis
Genomic DNA was isolated from peripheral blood lymphocytes according to standard 
procedures. WES of members of families A, B and C was performed using Agilent’s 
SureSelect All Human Exome version 4 kit (Agilent Technologies, Santa Clara, CA, USA), 
followed by sequencing on a SOLiD4 sequencing platform (Life Technologies, Carlsbad, 
CA, USA) with an average depth of 80X. Exome capture for family D was performed using 
the Nextera Rapid Capture Expanded Exome kit (Illumina, San Diego, CA, USA), and 
sequenced on a HiSeq2500 platform (Illumina). Reads were subsequently mapped against 
the UCSC genome browser’s Human hg19 assembly (build 37) and variants were called 
using the Genome analysis Toolkit (GATK) v2 according to the recommended guidelines 
(https://software.broadinstitute.org/gatk/best-practices/).
Homozygosity mapping
Runs of homozygosity were determined using the online tool Homozygosity Mapper, using 
variant call format (*.vcf) file as an input file. Homozygous regions larger than 4 Mb were 
selected and ranked. Assuming autosomal recessive inheritance, we used the identity by 
descent (IBD) regions to narrow down candidate disease-associated variants identified from 
the WES data.
Sanger sequencing
Primers for amplification of coding exons and flanking exon-intron boundaries of IDH3A 
(NM_005530.2) were designed with Primer3 plus (http://www.bioinformatics.nl/cgi-bin/
primer3plus/primer3plus.cgi). Primer sequences and PCR conditions are available upon 
request.
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Variants identified in the WES data of probands A-II:2, B-II:1, C-II:1 and D-II:1 were 
filtered as follows: (1) Selection of variants with a minor allele frequency (MAF) ≤0.5% in a 
stringent and ≤1.5% in a less stringent filtering. MAFs were obtained from the Exome 
Aggregation Consortium (ExAC), dbSNP and in-house variant databases; (2) Classification 
of variants based on their effect (nonsense, frameshift, missense or splice site); (3) Selection 
of variants that occurred in homozygous or compound heterozygous state; (4) Assess the 
pathogenicity of candidate variants using the Combined Annotation Dependent Depletion 
(CADD) (http://cadd.gs.washington.edu/) score. This program incorporates several widely 
used in silico tools, such as SIFT (http://sift.jcvi.org/), PolyPhen-2 (http://
genetics.bwh.harvard.edu/pph2/), Mutation Taster (http://www.mutationtaster.org/), PhyloP 
and Grantham score. SIFT predicts whether an amino acid substitution affects protein 
function, PolyPhen-2 predicts whether an amino acid substitution affects protein structure 
and function, and Mutation taster estimates the impact of a variant on the protein and the 
gene product. PhyloP scores measure evolutionary nucleotide conservation at individual 
alignment sites; positive scores are associated with conserved regions compared to the 
evolution expected under neutral drift. Finally, the Grantham score represents the 
evolutionary distance between two amino acids, the more distant two amino acids are, the 
more damaging their substitution is.
Results
Clinical findings
We ascertained seven patients from four families, between the ages of 3 to 26 years. Their 
clinical characteristics are summarized in Table 1 and the family pedigrees are shown in 
Figure 1. All patients had early onset night blindness and were diagnosed between the ages 
of 1 and 11 years (y). Visual acuity (VA) was available for all patients and ranged from 
20/20 to counting fingers (CF) at 1 meter.
The youngest patient (A-II:2) of a Dutch family was diagnosed with a macular 
pseudocoloboma at the age of 1 y and was referred to the Rotterdam Eye Hospital with 
decreased VA and strabismus at 3 y of age. At that stage, VA was CF with a fine horizontal 
nystagmus. On fundus examination, a macular pseudocoloboma was noted with peripheral 
RPE alterations (Figure 2D). The dimensions of the pseudocoloboma appeared unchanged 
and VA remained stable at age 5 y. The OCT scan showed severe atrophy of the outer retinal 
layers and the RPE at the colobomatous lesion (Figure 2E). With ERG testing no responses 
could be distinguished from noise level under light-and dark-adapted circumstances. His 
family history revealed that his sister (A-II:1), who was 3 years older, suffered from night 
blindness. Although her visual acuity was still normal, RPE alterations were noted at her 
macula, and OCT scans showed subfoveal alterations of the ellipsoid zone, confirming early 
macular involvement (Figures 2A, B). The fundus camera-based autofluorescence image 
appears dark because of underexposure with a very low sensitivity setting during acquisition; 
the autofluorescence of the posterior pole looks intact. Fundus examination also revealed 
early signs of peripheral degeneration, and ERG and Goldman visual field testing were 
compatible with the diagnosis of RP.
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The Israeli family included two affected siblings, an older brother and a younger sister 
(Figure 1, Table 2), who were evaluated at age 11 y, based on suspicion of night blindness. 
Best-corrected visual acuity (BCVA) in the eldest sibling (B-II:1) was well preserved up 
until his last exam at 18 y of age (20/20 in both eyes with hyperopia), despite severe bilateral 
cystoid macular edema (CME) (Figures 2G, H) that was noted already at age 12 y. CME was 
treated although visual acuity was optimal but remained refractory to multiple trials of 
treatment with systemic and topical carbonic anhydrase inhibitors as well as topical 
Voltaren® drops. On fundus examination mid -peripheral bone spicule-like pigmentations 
and atrophy were noted (Figure 2F), ffERG testing and Goldman visual field testing were 
compatible with his symptoms and the RP phenotype. Color vision testing using the Ishihara 
38-plate and the Farnsworth D-15 panel was within normal limits. OCT and fundus 
autofluorescence imaging reflect CME and peripheral atrophy of the outer segments 
(Figures 2G, H). BCVA in his younger sister (B-II:2) was also preserved up until her last 
exam at age 15 y (20/20 in both eyes), with myopic correction. Fundus findings (Figure 2I) 
include normal-appearing optic discs and blood vessels, an abnormal macular reflex without 
CME, and subtle RPE alterations with mild bone spicule-like pigmentations nasal>temporal 
in the mid-periphery. ffERG testing revealed better responses than those observed in her 
brother at the same age (Table 1). Goldmann visual fields to a IV4e target were preserved 
and color vision was normal. OCT imaging showed that the outer nuclear layer was still 
present in the foveal area, but markedly thins out in parafoveal regions (Figure 2J). An 
hyper-autofluorescent ring was seen in the maculas and hypo-autofluorescent patches were 
present beyond the vascular arcades (Figure 2F).
An isolated case of Dutch descent (C-II:1) was referred to the Leiden University Medical 
Center with complaints of night blindness at the age of 10 y. BCVA was suboptimal at last 
examination (OD 16/20, OS 18/20) with myopic correction. On fundus examination, typical 
RP features were present (Figure 2L). ffERG showed severely reduced dark- and light-
adapted responses. Visual fields were severely constricted (10° radius). On OCT imaging 
extensive peripheral degeneration was seen with distortion of the macular alterations of the 
outer segments and RPE architecture (Figure 2M).
Two South African sisters (D-II:2, D-II:3) (Figure 1) had an onset age of 8 y with 
complaints of night blindness and decreased visual acuity. In their early twenties, both were 
diagnosed with a rapid progressive form RP and macular pseudocoloboma. Their vision at 
that stage was limited to counting fingers at 1 meter. Fundus examination revealed severe 
mid-peripheral bone spicule pigmentary changes, mild arteriolar narrowing, 
pseudocoloboma of the macula and optic atrophy (Figure 2N). The youngest sister was 
examined 4 years later (Figure 2N). At that time the oldest sister had died due to an 
unrelated infection. The fundus autofluorescence was strongly reduced within the macula 
(Figure 2P), the optic disk appears white as result of an inaccurate sensitivity setting during 
acquisition. The OCT showed macular atrophy and confirmed the pseudocoloboma, also 
showing lamellar disorganization (Figure 2O).
The disorder did not seem to be associated with distinct hypermetropia or myopia, early-
onset cataract, or keratoconus. Both the deceased patient from South Africa and the male 
patient from Israel developed edema of the lower extremities. In the South African patient 
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the bilateral edema was thought to be caused by low serum albumin, but in the Israeli patient 
no cause could be appointed for the unilateral edema after a thorough work-up. The 
significance of this is unknown and no additional systemic disorders were detected, nor any 
systemic associations.
Genetic findings
WES revealed biallelic variants in IDH3A in seven patients from four families, and are 
summarized in Tables 1 and 2. All variants were novel and no other pathogenic variants 
were found in other genes after WES in families A and B.
Sequencing of nicotinamide nucleotide adenylyltransferase 1 (NMNAT1), a candidate gene 
for this phenotype, in subject A-II:2, did not reveal a suspected disease-causing variant and 
neither did targeted sequencing of a panel of 256 genes associated with inherited vision 
disorders, including known IRD-associated genes. Subsequently, analysis of the complete 
exome was performed and two variants in IDH3A were found. No alternative candidate 
variants remained after filtering. Additional genetic testing of his sister and parents showed 
that the variants segregated with the disease phenotype (Figure 1). Screening of IDH3A in 
WES data from 121 isolated unsolved RP/arRP cases did not reveal additional cases with 
IDH3A variants and IBD data from 199 unsolved isolated RP/arRP cases did not reveal 
homozygous regions > 4 Mb that spanned the IDH3A gene.
In parallel, a genetic analysis of Family B (MOL0655), which included Sanger sequencing 
of founder mutations previously identified in RP patients of Jewish origin, followed by trio 
WES analysis (two affected siblings and their mother), revealed compound heterozygous 
variants in IDH3A (p.(Pro304His); p.(Met313Thr)) in subjects B-II:1 and B-II:2. No 
alternative candidate variants remained after filtering. Screening the IDH3A variants in a set 
of 261 ethnically-matched Israeli index cases with RP did not reveal other cases with these 
variants. In addition, we scrutinized homozygosity mapping data of 193 families. Twelve 
showed homozygosity of the IDH3A region but Sanger sequencing of the exons of IDH3A 
revealed no additional variants. This family was part of a cohort of 138 families with 
isolated RP/arRP in which WES was performed and led to a molecular diagnosis was in 56 
families.
Using Homozygosity Mapper, we identified eight homozygous regions larger than 30 Mb in 
patient C-II:2. WES data analysis did not yield any variants in IRD genes that are located 
within this region. Upon stringent filtering step, two homozygous missense changes, i.e. in 
IDH3A (p.(Ala175Val) and TSPAN3 (p.(Arg80Cys)), remained as candidate variants (Table 
2). The TSPAN3 variant, p.(Arg80Cys), had a minor allele frequency of 0.0017 in the ExAC 
database and was predicted to be benign by SIFT and PolyPhen2 in silico prediction tools, 
but had a high PhyloP (3.4), Grantham (180) and CADD-Phred score (15.70). Northern blot 
analysis and data from an expressed sequence tag (EST) database demonstrated a ubiquitous 
gene expression16.
Subject D-II:1 was previously analyzed using an ABCA4 Microarray from Asper Biotech 
(558 variants) using arrayed-primer extension technology,17 and subsequently using an LCA 
Microarray 17 (780 variants in 15 LCA-associated genes), both revealing no causal variants. 
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Exome sequencing of a panel of 217 known IRD-associated genes was negative18, but 
analysis of ERDC candidate genes (http://www.erdc.info/candidateirdgenes) revealed 
biallelic variants in IDH3A which segregated with the disease phenotype (Figure 1). 
Screening of these variants in a set of 16 indigenous African families (n=56 individuals) 
with IRDs was negative.
In total, seven different variants were detected in IDH3A in our cases. The resulting 
transcripts of the two nonsense variants (p.(Thr135fs*), p.(Gly155*)) are predicted to 
undergo nonsense mediated decay, suggesting that these variants are true loss-of-function 
alleles. All missense variants (p.(Ala175Val), p.(Met239Thr), p.(Pro304His), p.
(Met313Thr), p.(Arg316Cys)) were indicated as pathogenic by in silico prediction tools 
(Table 2). All missense variants were located at conserved residues of the IDH3A protein 
(Figure 3), and fall within the conserved mitochondrial NAD-dependent IDH domain - a 
conserved nucleotide binding domain typical of NAD- or NADP-dependent dehydrogenases 
(NCBI’s conserved domain database). The p.(Ala175Val) variant is located in a region that 
is in close contact with other IDH3 subunit(s). The impact of the variant on the structure is 
minor; however due to its critical location, it may disrupt the binding between subunits to 
form the IDH3 complex as the valine amino acid is slightly bulkier than alanine (Figure 4). 
The p.(Met239Thr) missense variant affects an amino acid residue buried in the core close to 
the interaction surface with the IDH3 gamma subunit (Figure 4). The smaller size of 
threonine will disturb the stabilizing hydrophobic interactions and might affect subunit 
interaction. The p.(Pro304His) missense variant might affect the interaction with the NADH 
ligand (Figure 4). The proline is predicted to be located closely to the NADH ligand, which 
allows them to interact. The rigidity of proline provides a stable structure for the interaction 
with the ligand. Hence, this alteration may destabilize and deform the rigid structure, and 
affect the interaction with the ligand. Moreover, histidine is a large amino acid, which may 
also alter the van der Waals atomic contacts with other amino acids nearby. The p.
(Met313Thr) missense variant has no predicted impact on the protein structure but changes 
the hydrophobic amino acid to polar. Thus any hydrophobic activity needed in this position 
will be reduced. Lastly, the p.(Arg316Cys) missense variant is located in the same helix as 
mutant p.(Met313Thr). However, the arginine sidechain is located on the surface where it 
can make stabilizing ionic interactions with glutamic acid 328. The insertion of cysteine at 
this position does not have a big effect on the size of the amino acid at this position, but the 
stabilizing interaction in this domain will be affected. Additionally, a reactive sulfur atom 
will appear on the surface of the protein.
Discussion
In this study, we identified novel variants in IDH3A in four cases with typical arRP and 
three cases with arRP and macular pseudocoloboma from four unrelated families. These 
families originated from the Netherlands, Israel, and South Africa. All patients had visual 
complaints early in life ranging from night blindness to severe visual impairment. In patients 
with RP and macular pseudocoloboma (A-II:2, D-II:2 and D-II:3) the visual impairment was 
more severe than in patients with isolated RP (A-II:1, B-II:1, B-II:2 and C-II:1), which 
might explain why they were diagnosed at a younger age. The youngest patient with RP and 
pseudocoloboma (A-II:2) was three, whereas his sister (A-II:1) of six displayed only some 
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RPE alterations in the macular region with abnormalities in the ellipsoid zone on OCT 
examination with moderate reduced visual acuity (Table 1, Figure 2B). In two Israeli 
siblings (B-II:1 and B-II:2) without pseudocoloboma, the visual acuity and visual field 
remained optimal up until the last examination at age 16, despite bilateral severe CME in B-
II:1 (Figure 2G). In both siblings, the ellipsoid zone appeared normal in the macular region 
on OCT examination (Figure 2J).
IDH3A encodes the mitochondrial NAD+-specific IDHα subunit (IDH3A), a 339 amino 
acid long protein that is a part of the heterotetramer IDH3, comprised of two α subunits, one 
β subunit (the product of the IDH3B gene) and one γ subunit (the product of the IDH3G 
gene)19. IDH3 catalyzes the oxidation of isocitrate to α-ketoglutarate in the citric acid cycle, 
also known as the Krebs cycle. Recently, a homozygous missense IDH3A variant, p.
(Pro304His) was found in a patient suffering from severe infantile encephalopathy with 
peripheral and autonomic nervous system involvement20. Funduscopy at the age of 8 months 
revealed RP and bilateral optic atrophy. Functional studies in yeast confirmed the high 
evolutionary conservation of the IDH3 enzyme. Wild-type human IDH3A complemented the 
growth defect observed in IDH1- and IDH2-depleted yeast, but human IDH3A harboring the 
p.(Pro304His) variant could not complement yeast IDH1 and IDH2 function. This suggested 
that the variant has a significant impact on the function of IDH3A. The same variant is 
reported here by us to cause nonsyndromic RP in a compound heterozygous state with the p.
(Met313Thr) variant in two siblings. The phenotypic difference (severe infantile 
encephalopathy versus Nonsyndromic RP) might indicate that the p.(Pro304His) variant is 
responsible for a more severe and profound phenotype, while the p.(Met313Thr) variant is 
milder and limits the phenotype to the retina. Such correlations were reported in other RP-
associated genes including USH2A and some of the genes causing Bardet-Biedl 
syndrome21–24. Additionally, another group reported on a homozygous Idh3a missense 
variant, p.(Glu229Lys), in mice with an isolated RP phenotype25. This mutation was found 
in a large N-ethyl-N-nitrosourea mutagenesis screen.
Biallelic variants in IDH3B, coding for the IDHβ subunit, were previously described by 
Hartong et al. in three cases from two families with arRP26. A combination of expression 
analysis and direct sequencing revealed a homozygous frameshift variant that segregated 
with the disease. Screening of IDH3B in 546 unsolved cases with RP led to the discovery of 
a second homozygous missense variant. Subsequent functional studies showed a significant 
decrease in NAD-IDH activity in lymphoblast cell lysates from homozygous patients, 
compared with wildtype controls and heterozygous carriers. All patients with IDH3B 
variants presented with RP without macular pseudocoloboma or systemic involvement. As 
IDH3A codes for the two alpha subunits in the NAD-IDH enzyme, it is plausible that 
variants affecting the IDH3A protein influence NAD-IDH function in a similar manner as do 
IDH3B variants. There have been no reports on disease associations for the gene encoding 
the third component of the NAD-IDH enzyme, IDH3G, but it can be an interesting candidate 
gene for IRDs.
We deemed the homozygous TSPAN3 variant found in family C with homozygosity 
mapping less likely to be causal. Currently, there is no retinal disorder or retinal pathway 
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associated with variants in TSPAN3. In addition, the mutant cysteine residue at position 80 
is a wild-type amino acid in Tetraodon nigroviridis.
In our IDH3A cohort, patients carried two missense variants or a combination of a missense 
and a null variant. Some missense variants might be hypomorphic variants that allow for 
residual IDH3A activity. Remarkably, all patients with arRP and macular pseudocoloboma 
carried a null variant, which could explain the more severe phenotype. However, one sibling 
with only mild foveal abnormalities carried the same null and missense variant as her 
brother who had a macular pseudocoloboma. This difference in phenotype could be caused 
by differences in IDH3A expression between the siblings. A higher expression of the mutant 
IDH3A carrying the missense variant in the typical arRP sibling could potentially result in 
the milder phenotype. But, the NAD-IDH protein complex is subject to strict stoichiometric 
rules, so it is also possible that different expression levels of IDH3B and IDH3G influence 
the phenotypic outcome.
RPE abnormalities at the macula at an early stage are more frequently observed in IRDs 
caused by mutations in genes associated with Leber congenital amaurosis and early-onset 
RP (e.g. CRB1). Rarely noted is a macular pseudocoloboma, a somewhat uncomfortable 
term used to describe early and distinct degeneration of a normally appearing macula. 
‘Macular coloboma’ is often misused for describing atrophic lesions in the central retina, 
where true coloboma are the result of failed or incomplete closure of the embryonic fissure 
during the sixth and seventh week of fetal development and are often associated with 
microphthalmos or other closure defects. Macular pseudocoloboma was first described by 
Clausen in 1921 in a family with a dominant inheritance pattern and no systemic 
involvement27. They were also mentioned in Foxman’s classification of congenital and 
early-onset RP as a ‘common’ finding in patients with uncomplicated (or non-syndromic) 
LCA6. Since molecular diagnostics has become more widely available we acknowledge that 
mutations in different genes involved in various pathways underlying genetic vision 
disorders can be causal. Pseudocolobomas are characteristic for nicotinamide nucleotide 
adenylyltransferase 1 NMNAT1-associated LCA28–31, DEAH box polypeptide 38 (DHX38)-
associated RP32, and North Carolina type macular dystrophy (NCMD)33, 34, all in which 
macular atrophy is caused by early-onset neurodegeneration28.
NMNAT1 is an essential enzyme for regenerating the nuclear pool of NAD+ in all nucleated 
cells in the body and plays a role in neuroprotection28–31. Pseudocolobomas in patients with 
NMNAT1-associated LCA are the result of retinal degeneration after normal anatomical 
development, in contrast to true coloboma where the retinal structure was abnormally 
developed in utero. Mice studies support these findings and show that photoreceptors are 
extremely susceptible to NMNAT1 dysfunction as their metabolic activity is very high35. 
The need for NAD+ is critical after light exposure and cannot be met when enzymatic 
NMNAT1 activity is disrupted28. RPE cells and inner retinal cells undergo degeneration to a 
lesser extent35.
A homozygous variant in DHX38 was found in a Pakistani patient with early-onset RP and 
macular pseudocoloboma32. DHX38 encodes the pre-mRNA splicing factor PRP16, that is 
involved in catalyzing the second step in pre-mRNA splicing. Splicing factor genes are 
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widely expressed, but mutations in some of these genes, such as PRPF3, PRPF8, PRPF31 
and SNRNP2000, exclusively result in retinal degeneration without other systemic 
manifestations.33, 3436, 373838 32, 39
All genes associated with macular pseudocoloboma are widely expressed and are involved in 
different pathways, such as energy metabolism (IDH3A, NMNAT1), pre-mRNA splicing 
(DHX38) and transcription control (PRDM13). However, the disease manifestation seems to 
be restricted to the retina. Possible explanations might be the exceptionally high metabolic 
turnover in photoreceptor cells, which requires significantly more energy and higher levels 
of pre-mRNA splicing molecules compared with other cell types. Alternatively, other factors 
or pathways may compensate for this high consumption in other cell types. There are no 
reports on IRD patients with two null variants in IDH3A, NMNAT1, and DHX38, which 
leads us to believe that complete inactivity of these proteins might be incompatible with life.
In conclusion, we identified seven (likely) pathogenic variants in IDH3A leading to typical 
arRP and arRP associated with macular pseudocoloboma in seven patients from four 
unrelated families. Thereby we have implicated a second subunit of the IDH3 protein 
complex to play a crucial role in the human retina.
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Pedigrees of families included in this study.
Pierrache et al. Page 14














Retinal imaging data for patients with IDH3A variants.
(Wide-field) color fundus photographs, optical coherence tomography OCT and fundus 
autofluorescence (FAF) imaging with fundus-camera-based autofluorescence photography 
or confocal scanning laser ophthalmoscopy (cSLO).
Patient A-II:1 at age 7 y, (A) pink optic discs, mildly attenuated blood vessels, RPE 
alterations in the fovea and periphery, (B) small central disruptions in the ellipsoid zone, (C) 
intact autofluorescence of the posterior pole.
Patient A-II:2 at age 3 y, (D) distinct atrophy of the RPE and choriocapillaris in the macular 
region demarcated by a hyperpigmented ring, peripheral RPE alterations, (E) atrophy of the 
RPE, abnormal outer retinal layers.
Patient B-II:1 at age 18 y, (F) mid-peripheral atrophy with bone spicule-like pigmentation 
nasal>temporal, OS>OD, (G) bilateral severe cystoid macular edema (RE>LE) with 
thickening of the retina and loss of normal foveal structure, thinning and loss of the 
photoreceptor nuclei layer (ONL) is evident in the para-macular regions of the scans, (H) 
hyper-autofluorescent ring around the fovea.
Patient B-II:2 at age 15 y, (I) mid-peripheral atrophy with bone spicule-like pigmentation 
nasal>temporal, OS>OD, (J) presence of the photoreceptor nuclei layer in the fovea without 
edema, but marked thinning and loss of the ONL is evident in para-macular regions, (K) 
prominent hyper-autofluorescent ring surrounding the center of the macula.
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Patient C-II:1 at age 20 y, (L) pale aspect of the optic disc, attenuated blood vessels, RPE 
alterations from mid-periphery towards the far periphery, (M) extensive peripheral atrophy 
of the outer segments and distortion of the foveal architecture.
Patient D-II:2 at age 26 y, (N) peripheral bone-spicule pigmentary changes, peripheral and 
mid-peripheral pigmentary retinopathy, macular pigmentation with severe pseudocoloboma-
like atrophy, mild arteriolar narrowing and mild optic atrophy, (O) macular atrophy with 
lamellar disorganization, (P) strongly reduced autofluorescence within the macula, diffusely 
increasing in a broad ring around the macula, and fading towards the periphery.
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Multiple sequence alignment of IDH3A orthologs around missense variant sites (highlighted 
in light blue) generated by NCBI HomoloGene. Amino acids highlighted in grey are not 
identical to the corresponding amino acid in the human ortholog.
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3D structure of the IDH3 complex and the location of the missense variants.
The IDH3 protein complex contains two alpha subunits (pink, yellow), one beta subunit 
(purple) and one gamma subunit (blue). Missense variants are indicated in red in only one of 
the two alpha subunits for clarity. In patients with compound heterozygous variants, the 
NAD-IDH complex may consist of two identical alpha subunits altered by the same variant 
or two different alpha subunits.
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